logofg

ANTICIPATE
Hypertension

High blood pressure and menopause: test and act to avoid cardiovascular accidents!

Menopause is associated with a significant increase in arterial and metabolic risk. Arterial hypertension is common in post-menopausal women, with one in two women over the age of 55 having a blood pressure greater than or equal to 140/90 mm Hg.

High blood pressure and menopause: test and act to avoid cardiovascular accidents!

Repeated measurement of blood pressure should be routine at every consultation. Ambulatory measurements, outside the doctor's office, should be encouraged, as nocturnal blood pressure screening is particularly cost-effective in the prevention of cardiovascular disease in women. Self-measurement of blood pressure with a device worn on the arm (rather than the wrist) should be encouraged in the menopause. Self-measurement is based on the "rule of 3": 3 blood pressure readings in the morning on waking, in a quiet seated position, and three blood pressure readings in the evening before going to bed, in a quiet seated position, on three consecutive days. The average of the 18 measurements must be strictly below 135/85 mm Hg to qualify as normotension. After ambulatory confirmation of hypertension, anti-hypertensive treatment will be initiated, in conjunction with a healthier lifestyle (particularly reduced salt and alcohol consumption), taking into account the overall level of cardiovascular risk. There are no specific therapies to promote in hypertensive women, with the exception of thiazide diuretics in osteoporotic women. In hypertensive women under 60 with incapacitating climacteric symptoms and no history of arterial or venous cardiovascular disease, transdermal hormone therapy alone may be proposed within 10 years of the onset of menopause, subject to prior consultation between the gynecologist, cardiologist and attending physician, and to informed notification of the benefit-risk balance of hormone therapy recorded in the medical record. In France, cooperation between cardiovascular physicians, gynecologists and GPs should be promoted to optimize the care of these at-risk women and improve professional practices. This is one of the three missions of Agir pour le Cœur des femmes, to help set up care paths around women's health, based on its flagship screening and alert campaign, the Bus du Cœur des Femmes.

 
SEE ALSO

Aortic aneurysm: male/female differences finally taken into account

VASCULAR MEDICINE

An aneurysm is defined as an increase in the size (diameter) of an artery of more than 50% compared with the normal value: if the normal value is 20 mm, the anomaly starts at 30 mm. Aneurysms can be located in any artery, with particular attention paid to the aorta (the largest artery) in the [...]

Read more

Infertility and the risk of cardiovascular disease: consider them in the context of all risk factors

Gynecology

Cardiovascular disease has different risk factors for men and women. An increasing number of scientific studies are specifically analyzing the influence of reproductive factors and women's obstetrical history. While the latter (hypertensive disorders, preeclampsia, repeated miscarriages, etc.) [...]

Read more

Anticipate and act: sleep apnea treatment, an informed choice after a consultation!

Pneumology

It is now well established that severe sleep apnea syndrome (SAS) (apnea-hypopnea index (AHI) >30/hour) is a major cardiovascular risk factor, particularly for hypertension and heart rhythm disorders. Treating it effectively on a daily basis can reduce or even eliminate this cardiovascular risk [...]

Read more

 Your donation will help improve
prevention at the key moments
of a woman's life